Skip to main content

Exane Derivatives

SEC CIK
0001623883
Latest filing
Jul 12, 2022

WGS holding history

GeneDx Holdings Corp. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WGS overviewAll 13F holders of WGSFull Q2 2022 holdings

Shares (Q2 2022)
62,153
Value
$78.3K
% of portfolio
<0.1%
Quarters held
3
Since Q3 2021
Holdings of WGS by Exane Derivatives, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202262,153$78.3K<0.1%+62,153NewHolders
Q1 20220$00.0%−62,153−100.0%Sold outHolders
Q4 202162,153$277.2K0.1%+20,400+48.9%AddedHolders
Q3 202141,753$316.9K0.1%+41,753NewHolders